Dharmaj Crop Guard IPO - Outlook, Valuation, Future Strategies, Risks, Financials: KRChoksey

We believe the company's long-term prospects are favorable, given the fact that it is an emerging player in agrochemicals space.
<div class="paragraphs"><p>Spraying pesticide in an open field. (Source: Company website)</p></div>
Spraying pesticide in an open field. (Source: Company website)

BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy. 

KRChoksey Research's IPO Report

Dharmaj Crop Guard Ltd. is an agrochemical company engaged in the business of manufacturing, distributing and marketing of a wide range of agrochemicals such as insecticides, fungicides, herbicides, plant growth regulator, micro fertilisers and antibiotic to the business-to-consumer and business-to-business customers.

Dharmaj Crop Guard exports its products to more than 20 countries in Latin America, East African countries, Middle East and Far East Asia. It sells its agrochemical products in granules, powder and liquid forms.

Dharmaj Crop Guard has obtained 464 registrations for agrochemical formulations from the Central Insecticides Board and Registration Committee, out of which 269 agrochemical formulations are for sale in India as well as for export and 195 agrochemical formulations are exclusively for exports.

It has 157 trademark registrations including branded products. Its formulations are sold as branded products to customers. As of September 30, 2022, Dharmaj Crop Guard hadover 118 branded formulations that are sold to farmers.

Click on the attachment to read the full IPO report:

KRChoksey Dharmaj Crop Guard IPO Note.pdf


This report is authored by an external party. BQ Prime does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BQ Prime.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

Get Regular Updates